The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is up 17% over the past year, to $2.56 per unit.
Market view
mesalamine · Capsule, Delayed Release
2 marketed package NDCs · 2 active manufacturers
Most dispensed: 1.2 g · Tablet, Delayed Release · #120 tablet, delayed releases/bottle · .375 g · Capsule, Extended Release · #120 capsule, extended releases/bottle · 800 mg · Tablet, Delayed Release · #180 tablet, delayed releases/bottle · 1000 mg · Suppository · #5 packages/carton / 6 suppository in 1 package
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $2.56 · middle half $2.56–$2.56 · full range $2.56–$2.56 · 2 products · 2 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for mesalamine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- MesalamineAug 27, 2026New shortageby this manufacturerMylan Pharmaceuticals Inc., a Viatris Company's Mesalamine (Capsule, Extended Release, .375 g) is newly in shortage61 companies market mesalamine
- MesalamineAug 19, 2026Price downNADAC $0.81924 → $0.79534 per unit (-2.92%)
- MesalamineAug 19, 2026Price downNADAC $0.09966 → $0.09744 per unit (-2.23%)
- MesalamineAug 19, 2026Price downNADAC $1.30434 → $1.2867 per unit (-1.35%)
- Mesalamine RectalAug 19, 2026Price downNADAC $1.30434 → $1.2867 per unit (-1.35%)
- mesalamineAug 19, 2026Price downNADAC $0.81924 → $0.79534 per unit (-2.92%)
- MesalamineAug 19, 2026Price upNADAC $0.4832 → $0.48654 per unit (+0.69%)
- mesalamineAug 19, 2026Price downNADAC $4.08413 → $4.0027 per unit (-1.99%)
- MesalamineAug 19, 2026Price upNADAC $0.4832 → $0.48654 per unit (+0.69%)
- MesalamineAug 19, 2026Price downNADAC $4.08413 → $4.0027 per unit (-1.99%)
Same drug class
Other molecules FDA puts in Aminosalicylate, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Mesalamine in shortage right now?
- No. FDA does not currently list Mesalamine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Mesalamine?
- 61 companies have marketed Mesalamine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Mesalamine cost?
- The typical pharmacy pays about $0.7953 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.